文献速递胸部CT

健康筛查队列中CT间质性肺异常的患病率与长期结局

Prevalence and Long-term Outcomes of CT Interstitial Lung Abnormalities in a Health Screening Cohort.
PubMed 文献 · Radiology · 2022-10-11

这项回顾性多中心观察研究纳入2765例50岁以上接受胸部CT的健康筛查者,ILA患病率约3%,其中纤维型ILA占多数。纤维型ILA独立关联ILA进展、肺癌发生、疾病特异性和全因死亡率升高,8年内ILA进展率达80%。

要点

  • 健康筛查人群ILA患病率约3%,需在胸部CT报告中规范描述并分类为纤维型或非纤维型。
  • 纤维型ILA是ILA进展、肺癌发生和死亡的独立危险因素,应提示临床随访。
  • ILA患者8年内进展率高达80%,建议对ILA尤其是纤维型ILA进行规律CT随访。

核心结论

  • 亚洲健康筛查队列中ILA患病率约3%,纤维型ILA为ILA进展、肺癌发生及死亡的独立危险因素。

研究设计与样本

  • 回顾性多中心观察研究,纳入2007-2010年间三个健康筛查中心50岁以上接受胸部CT者2765例,中位年龄59岁。
  • ILA状态分为无、可疑ILA和ILA(非纤维型或纤维型),进展通过基线至末次随访CT评估。
  • 采用log-rank检验比较不同ILA状态死亡率,多变量Cox比例风险模型评估进展、肺癌和死亡的危险因素。

关键影像表现/征象

  • 94例(3%)检出ILA,其中非纤维型35例、纤维型59例;119例(4%)为可疑ILA。
  • 8年内ILA患者进展率为80%(48/60)。
  • 纤维型和非纤维型ILA患者12年死亡率均高于无ILA者(P < .001和P = .01)。

诊断标准与关键数值

  • 纤维型ILA对比无ILA:ILA进展HR 10.3(95%CI: 6.4, 16.4; P < .001)。
  • 纤维型ILA对比无ILA:肺癌发生HR 4.4(95%CI: 2.1, 9.1; P < .001)。
  • 纤维型ILA对比无ILA:疾病特异性死亡HR 6.7(95%CI: 3.7, 12.2; P < .001)。
  • 纤维型ILA对比无ILA:全因死亡HR 2.5(95%CI: 1.6, 3.8; P < .001)。

临床应用与阅片要点

  • 胸部CT阅片时应将间质性改变分类为无、可疑ILA、非纤维型ILA或纤维型ILA,并在报告中明确。
  • 检出纤维型ILA时应在报告中提示其与肺癌发生和死亡风险升高相关,建议临床结合随访。
  • 对ILA患者尤其纤维型ILA,应建议规律CT随访以监测进展。

局限性

  • 回顾性观察设计,仅部分患者有随访CT用于进展评估。
  • 研究人群为亚洲健康筛查者,结论外推至其他人群需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Background The association between interstitial lung abnormalities (ILAs) and long-term outcomes has not been reported in Asian health screening populations. Purpose To investigate ILA prevalence in an Asian health screening cohort and determine rates and risks for ILA progression, lung cancer development, and mortality within the 10-year follow-up. Materials and Methods This observational, retrospective multicenter study included patients aged 50 years or older who underwent chest CT at three health screening centers over a 4-year period (2007-2010). ILA status was classified as none, equivocal ILA, and ILA (nonfibrotic or fibrotic). Progression was evaluated from baseline to the last follow-up CT examination, when available. The log-rank test was performed to compare mortality rates over time between ILA statuses. Multivariable Cox proportional hazards models were used to assess factors associated with hazards of ILA progression, lung cancer development, and mortality. Results Of the 2765 included patients (mean age, 59 years ± 7 [SD]; 2068 men), 94 (3%) had a finding of ILA (35 nonfibrotic and 59 fibrotic ILA) and 119 (4%) had equivocal ILA. The median time for CT follow-up and the entire observation was 8 and 12 years, respectively. ILA progression was observed in 80% (48 of 60) of patients with ILA over 8 years. Those with fibrotic and nonfibrotic ILA had a higher mortality rate than those without ILA (P < .001 and P = .01, respectively) over 12 years. Fibrotic ILA was independently associated with ILA progression (hazard ratio [HR], 10.3; 95% CI: 6.4, 16.4; P < .001), lung cancer development (HR, 4.4; 95% CI: 2.1, 9.1; P < .001), disease-specific mortality (HR, 6.7; 95% CI: 3.7, 12.2; P < .001), and all-cause mortality (HR, 2.5; 95% CI: 1.6, 3.8; P < .001) compared with no ILA. Conclusion The prevalence of interstitial lung abnormalities (ILAs) in an Asian health screening cohort was approximately 3%, and fibrotic ILA was an independent risk factor for ILA progression, lung cancer development, and mortality. © RSNA, 2022 Online supplemental material is available for this article. See also the editorial by Hatabu and Hata in this issue.

来源:Radiology,查看原文。版权归原作者所有。

引用

  1. Lee, Chae, Suh, et al. Prevalence and Long-term Outcomes of CT Interstitial Lung Abnormalities in a Health Screening Cohort. Radiology. 2022. PMID: 36219115. doi:10.1148/radiol.221172

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。